Seroprevalence rate after one dose of varicella vaccine in infants
Authors:
- Eun Hwa ChoiECEun Hwa Choi
- 1 July 2010
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 61 (1) , 66-72
Abstract
No abstract availableKeywords
Funding Information
- Korean Food and Drug Administration Research Fund (2007-07102-452)
This publication has 30 references indexed in Scilit:
- Varicella Prevention in the United States: A Review of Successes and ChallengesPediatrics, 2008
- Primary Vaccine Failure after 1 Dose of Varicella Vaccine in Healthy ChildrenThe Journal of Infectious Diseases, 2008
- Varicella Vaccination in Japan, South Korea, and EuropeThe Journal of Infectious Diseases, 2008
- Varicella Vaccine Effectiveness in the US Vaccination Program: A ReviewThe Journal of Infectious Diseases, 2008
- Loss of Vaccine-Induced Immunity to Varicella over TimeNew England Journal of Medicine, 2007
- Decline in Mortality Due to Varicella after Implementation of Varicella Vaccination in the United StatesNew England Journal of Medicine, 2005
- A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX? in healthy children*1Vaccine, 2002
- The Effectiveness of the Varicella Vaccine in Clinical PracticeNew England Journal of Medicine, 2001
- Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccineThe Journal of Pediatrics, 1995
- Detection of antibodies to varicella-zoster virus using a latex agglutination assayClinical and Diagnostic Virology, 1994